Fetal growth pathology score: a novel ultrasound parameter for individualized assessment of third trimester growth abnormalities.

ABSTRACT:

Objectives

To study fetal growth in pregnancies at risk for growth restriction (GR) using, for the first time, the fetal growth pathology score (FGPS1).

Methods

A retrospective cohort study of GR was carried out in 184 selected SGA singletons using a novel, composite measure of growth abnormalities termed the FGPS1. Serial fetal biometry was used to establish second trimester Rossavik size models and determine FGPS1 values prior to delivery. FGPS1 data were compared to neonatal growth outcomes assessed using growth potential realization index (GPRI) values (average negative pathological GPRI (av - pGPRI)). Growth at the end of pregnancy was evaluated from differences in negative, individual composite prenatal growth assessment scores (-icPGAS) measured at the last two ultras

SUBMITTER: Deter RL 

PROVIDER: S-EPMC5813490 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature